CHA News Article

Investigational Drug Available for Treatment of Free-Living Ameba Infections

The Centers for Disease Control and Prevention (CDC) now has an expanded-access investigational new drug protocol in effect with the Food and Drug Administration to make miltefosine available directly from CDC for treatment of free-living ameba infections in the U.S. A recent update issued by the Health Alert Network — including background information, recommendations and links to additional resources — is available on the CDC website at